Epidemiology of the metabolic syndrome and the RISC study

European Heart Journal, Supplement

Volumn 7, Issue D, 2005, Pages

  Balkau, Beverley ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1;

CONFERENCE PAPER; ENVIRONMENTAL FACTOR; GENETICS; GLUCOSE BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 20744448675     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sui022     Document Type: Conference Paper

References (12)

1. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation 1999.
2. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diabetes Med 1999;16:442-443.
3. NCEP Expert Panel on the Detection, Evaluation and Treatment of High Blood Pressure in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection and evaluation and treatment of high cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
4. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
5. Balkau B, Charles MA, Drivsholm T et al. Frequency of the WHO metabolic syndrome in European cohort and an alternative definition of insulin resistance syndrome. Diabetes Metab 2002;28:364-376.
6. Balkau B, Vernay M, Mhamdi L et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003;29:526-532.
7. Gomila S, Dallongeville J. Epidémiologie du syndrome métabolique en France. [French] Med Nutr 2003;39:89-94.
8. Ford ES, Giles WH, Dietz WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-581.
9. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1597-1607.
10. Haffner SM, Valdez RA, Hazuda HP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-722.
11. Weyer C, Hanson RL, Tataranni PA. A high plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathologic role of relative hyperinsulinaemia. Diabetes 2000;49:2094-2101.
12. Hills SA, Balkau B, Coppack SW. The EGIR-RISC Study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): 1. Methodology and objectives. Diabetologia 2004;47:566-570.